track [0.3 ng/mL).:] FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug 10 + years Approval History FDA approved 1997 Manufacturer Novartis Pharmaceuticals Corporation Drug Class Ophthalmic antihistamines and decongestants Related Drugs ophthalmic antihistamines and decongestants azelastine ophthalmic , Pataday , Patanol , phenylephrine ophthalmic , olopatadine ophthalmic , Zaditor Conjunctivitis, Allergic prednisone , prednisolone ophthalmic , azelastine ophthalmic , Deltasone , Zaditor , cromolyn ophthalmic , doxylamine , Optivar , Alaway , ketotifen ophthalmic , Bepreve , Lastacaft , Sterapred , triprolidine , bepotastine ophthalmic , carbinoxamine , alcaftadine ophthalmic , Equate Sleep Aid , Carboxine , Elestat , epinastine ophthalmic , Prednicot , Palgic , More... Emadine Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! customer service
surgery Emadine most efficient
EmoticonEmoticon